Tulip Medical Ltd. is a medical device company that is developing the next generation solution for the worldwide overweight and obesity epidemic. Tulip is focused on the self-pay and medically-insured overweight and mild obese market. According to the World Health Organization, there were more than 1.2 billion overweight and obese adults globally in 2005.

The Company’s flagship product is a unique orally taken biodegradable solution wherein patients will experience a long term feeling of satiety free of the severe complications associated with existing solutions. Tulip has developed a disposable medical device that is swallowed as a regular capsule. The device does not necessitate any invasive procedure or any new medications or chemicals and is comprised of FDA approved materials regularly used in the manufacture of pharmaceutical and food products.  The action of the device is purely mechanical and does not involve any chemical activity.

Tulip was incorporated in Israel in August 2005 by Dr. Shimon Eckhouse, Active Chairman and Doron Marco, CTO and is managed by Allon Reiter. The Company operates from its offices in Hertzelia, Israel.